SerGene Biosciences Ltd

Description

SerGene Biosciences. Accelerating Deal Success for Biotech Leaders SerGene Biosciences is a specialised commercial strategy and deal advisory firm dedicated to helping biotech leaders unlock their pipeline's true value and accelerate deal success. We partner with senior managers and leaders facing high-level strategic hurdles, such as linking pioneering science to a compelling market opportunity or securing the most advantageous terms in licensing, partnering, or M&A discussions. Our approach is Expert, Strategic, and Data-Driven. Our Core Value Proposition We combine deep commercial analysis, including risk-adjusted Net Present Value (rNPV) financial modelling, with "battle-tested" deal negotiation strategies. This unique blend of skills ensures that you not only understand your asset's value but can also convincingly articulate it to secure superior terms. Services Overview Strengthen Commercial Strategy. We build a clear, defensible commercial case for your assets, pressure-testing key assumptions using rigorous analytical tools like rNPV modelling. Optimize Portfolio Decisions. We leverage commercial insights to facilitate data-driven Go/No-Go decisions for clinical programmes, ensuring R&D investments target opportunities with the highest commercial potential. Negotiate Superior Deals. We provide continuous strategic counsel and negotiation support throughout partnership and M&A discussions to secure terms that truly reflect your asset’s potential. Our methodology is built on a proven personal track record. This includes developing the critical financial model that underpinned the successful negotiation of an $842.5 million deal while working at Oxford BioMedica.

Financials